Pharmaceutical Research

, Volume 18, Issue 11, pp 1634–1637

Physical and Chemical Enhancement of Transdermal Delivery of Triptorelin

  • Sara Nicoli
  • Silvia Rimondi
  • Paolo Colombo
  • Patrizia Santi
triptorelin luteinizing hormone-releasing hormone analogue transdermal iontophoresis lauric acid rabbit skin human skin 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    J. Sandow. Clinical applications of LHRH and its analogues. Clin. Endocrinol. 18:571-592 (1983).Google Scholar
  2. 2.
    L. L. Miller, C. J. Kolaskie, G. A. Smith, and J. Rivier. Transdermal iontophoresis of Gonadotropin Releasing Hormone (LHRH) and two analogues. J. Pharm. Sci. 79:490-493 (1990).Google Scholar
  3. 3.
    M. A. Hoitink, J. H. Beijnen, M.U. S. Boschma, A. Bult, O. A. G. J. van der Houwen, G. Wiese, and W. J. M. Underberg. Degradation kinetics of three gonadorelin analogues: developing a method for calculating epimerisation parameters. Pharm. Res. 15:1449-1455 (1998).Google Scholar
  4. 4.
    S. Nicoli, P. Colombo, S. Rimondi, and P. Santi. Rabbit ear skin permselectivity and transdermal iontophoresis. Proc. Intern. Symp. Control. Rel. Bioact. Mater. 28, #5001, Controlled Release Society Inc., 2001.Google Scholar
  5. 5.
    S. W. Smith and D. B. Anderson. Human skin permeability enhancement by lauric acid under equilibrium aqueous conditions, J. Pharm. Sci. 84:551-556 (1995).Google Scholar
  6. 6.
    N. M. Volpato, S. Nicoli, C. Laureri, P. Colombo, and P. Santi. In vitro acyclovir distribution in human skin layers after transdermal iontophoresis. J. Control. Release 50:291-296 (1998).Google Scholar
  7. 7.
    N. G. Turner, Y. N. Kalia, and R. H. Guy. The effect of current on skin barrier function in vivo: Recovery kinetics post-iontophoresis. Pharm. Res. 14:1252-1257 (1997).Google Scholar
  8. 8.
    P. Green, M. Flanagan, B. Shroot, and R. H. Guy. Iontophoretic Drug Delivery. In K. A. Walters, and J. Hadgraft (eds), Pharmaceutical Skin Penetration Enhancement, Marcel Dekker, New York, 1993, pp 320-322.Google Scholar
  9. 9.
    K. S. Bhatia and J. Singh. Synergistic effect of iontophoresis and a series of fatty acids on LHRH permeability through porcine skin. J. Pharm. Sci. 87:462-469 (1998).Google Scholar
  10. 10.
    M. Y. Lu, D. Lee, and G. S. Rao. Percutaneous adsorption enhancement of leuprolide, Pharm. Res. 9:1575-1579 (1992).Google Scholar
  11. 11.
    R. Panchagnula, K. Stemmer, and W. A. Ritschel. Animal models for transdermal drug Delivery. Meth. Find. Exp. Clin. Pharmacol. 19:335-341 (1997).Google Scholar
  12. 12.
    R. C. Wester and H. I. Maibach. Animal models for percutaneous absorption. In V. P. Shah and H. I. Maibach (eds), Topical Drug Bioavailability, Bioequivalence and Penetration, Plenum Press, New York, 1993, pp. 333-349.Google Scholar
  13. 13.
    J. Hirvonen, J. H. Rytting, P. Paronen, and A. Urtti. Dodecyl N,N-dimethylamino acetate and azone enhance drug penetration across human, snake, and rabbit skin. Pharm. Res. 8:933-937 (1991).Google Scholar
  14. 14.
    F. O. Muller, J. Terblanche, R. Schall, R. van Zyl Smit, T. Tucker, K. Marais, G. Groenewoud, H. C. Porchet, M. Weiner, and D. Hawarden. Pharmacokinetics of triptorelin after intravenous bolus administration in healthy males and in males with renal or hepatic insufficiency. Br. J. Clin. Pharmacol. 44:335-341 (1997).Google Scholar
  15. 15.
    O. Bouchot, J. Y. Soret, D. Jacqmin, N. Lahlou, M. Roger, and J. Blumberg. Three-month sustained-release form of triptorelin in patients with advanced prostatic adenocarcinoma: results of an open pharmacodynamic and pharmacokinetic multicenter study. Horm. Res. 50:89-93 (1998).Google Scholar

Copyright information

© Plenum Publishing Corporation 2001

Authors and Affiliations

  • Sara Nicoli
    • 1
  • Silvia Rimondi
    • 1
  • Paolo Colombo
    • 1
  • Patrizia Santi
    • 1
  1. 1.Department of PharmacyUniversity of ParmaParmaItaly

Personalised recommendations